Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543
NCT05467722
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Impairment
Interventions
DRUG:
CTP-543
Sponsor
Concert Pharmaceuticals